NCT00041639 - Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

December 31, 2003

Conditions

Pancreatic Neoplasms

Interventions

DRUG

hMN14 (labetuzumab)

Trial Locations (10)

University of Pittsburgh Cancer Institute, Pittsburgh

Washington Hospital Center, Washington D.C.

Bay Pines VA Medical Center, St. Petersburg

Hoag Cancer Center, Newport Beach

Virginia Mason Medical Center, Seattle

Medizinische Fakultaet der Charité Berlin, Berlin

Universitaetsklinikum Leipzig, Leipzig

Semmelweis University, Budapest

Medical University of Szeged, Szeged

Academic Medical Center, Amsterdam